Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer

More effective therapy for patients with either muscle‐invasive or high‐risk non‐muscle‐invasive urothelial carcinoma of the bladder (UCB) is an unmet clinical need. For this, drug repositioning of clinically approved drugs represents an interesting approach. By repurposing existing drugs, alternati...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Horst, Geertje, van de Merbel, Arjanneke F., Ruigrok, Eline, van der Mark, Maaike H., Ploeg, Emily, Appelman, Laura, Tvingsholm, Siri, Jäätelä, Marja, van Uhm, Janneke, Kruithof‐de Julio, Marianna, Thalmann, George N., Pelger, Rob C. M., Bangma, Chris H., Boormans, Joost L., van der Pluijm, Gabri, Zwarthoff, Ellen C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718956/
https://www.ncbi.nlm.nih.gov/pubmed/32896947
http://dx.doi.org/10.1002/1878-0261.12793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718956/
https://www.ncbi.nlm.nih.gov/pubmed/32896947
http://dx.doi.org/10.1002/1878-0261.12793

Ejemplares similares